Guidelinehigh evidence
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder.
Journal of addiction medicine·January 1, 2024·PMID 38669101
Why it mattersStimulant use disorder is a growing clinical challenge with limited FDA-approved pharmacotherapies. This guideline consolidates current best practices, emphasizing contingency management and off-label medication use, which can directly inform treatment planning and improve patient outcomes.

The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled